RecruitingNot Applicable

Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

United States198 participantsStarted 2022-02-01

Plain-language summary

Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age\>18 years * patient undergoing EBUS bronchoscopy with moderate conscious sedation. Exclusion Criteria: * subjects with previous nasal surgeries * subjects with oxygen saturation \<90% on room air prior to procedure * subjects who are pregnant * subjects with known facial fractures or recent facial trauma * subjects on any anticoagulation that cannot be discontinued prior to the procedure

What they're measuring

Number of interruption during EBUS procedure for hypoxia

Timeframe: 1 day

Trial details

NCT IDNCT05203328

SponsorThe Cooper Health System

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03

Contact for this trial

Wissam Abouzgheib, MD

(800) 826-6737 Abouzgheib-Wissam@cooperhealth.edu

View on ClinicalTrials.gov More Lung Cancer trials